Proteomics and severe acute respiratory syndrome (SARS): emerging technology meets emerging pathogen.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. What Can Proteomics Tell us About COVID-19 Infections? Mass Spectrometry as a Tool to Find New Proteins as Biomarkers.Current protein & peptide science · 2025
   Review
2. A comprehensive overview of proteomics approach for COVID 19: new perspectives in target therapy strategies.Journal of proteins and proteomics · 2020
   Review
3. Proteomics-based identification of plasma proteins and their association with the host-pathogen interaction in chronic typhoid carriers.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2014
   Article
4. Searching for the elusive typhoid diagnostic.BMC infectious diseases · 2010
   Review
5. Serum amyloid A is not useful in the diagnosis of severe acute respiratory syndrome.Clinical chemistry · 2006
   Article
6. Serum proteomic fingerprints of adult patients with severe acute respiratory syndrome.Clinical chemistry · 2006
   Article

Corrections and comments

• Comment on
  Protein chip array profiling analysis in patients with severe acute respiratory syndrome identified serum amyloid a protein as a biomarker potentially useful in monitoring the extent of pneumonia.2005
• Comment on
  Proteomic fingerprints for potential application to early diagnosis of severe acute respiratory syndrome.2005

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as